Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
APx Acquisition I Unit | APXIU | Nov 13, 2024 | 11.55 | 0.00 |
Apyx Medical | APYX | Nov 13, 2024 | 1.34 | -2.19 |
Aqua Metals | AQMS | Nov 13, 2024 | 1.95 | -5.80 |
AquaBounty Technologies | AQB | Nov 13, 2024 | 1.02 | -2.86 |
Aquaron Acquisition | AQU | Nov 13, 2024 | 11.00 | 0.00 |
Aquaron Acquisition Units | AQUNU | Nov 13, 2024 | 11.15 | 0.00 |
Aquestive Therapeutics | AQST | Nov 13, 2024 | 4.83 | -3.21 |
Aramark | ARMK | Nov 13, 2024 | 39.09 | +2.81 |
ARB IOT Group | ARBB | Nov 13, 2024 | 0.69 | -11.72 |
Arbe Robotics | ARBE | Nov 13, 2024 | 1.65 | -4.62 |
Arbor Realty Trust | ABR | Nov 13, 2024 | 15.32 | -1.16 |
Arbor Realty Trust D Pref | ABR-D | Nov 13, 2024 | 19.02 | +0.16 |
Arbor Realty Trust E Pref | ABR-E | Nov 13, 2024 | 19.54 | -0.05 |
Arbor Realty Trust F Pref | ABR-F | Nov 13, 2024 | 20.15 | -1.23 |
Arbutus Biopharma | ABUS | Nov 13, 2024 | 3.65 | +0.27 |
ARC Document Solutions | ARC | Nov 13, 2024 | 3.38 | 0.00 |
Arcadia Biosciences | RKDA | Nov 13, 2024 | 4.19 | -1.18 |
Arcadium Lithium | ALTM | Nov 13, 2024 | 5.25 | -0.94 |
ArcBest | ARCB | Nov 13, 2024 | 112.87 | -3.46 |
Arcellx | ACLX | Nov 13, 2024 | 100.14 | -0.34 |
Arcelor Mittal ADR | MT | Nov 13, 2024 | 23.77 | -2.34 |
Arch Capital F Pref | ACGLO | Nov 13, 2024 | 23.08 | +0.17 |
Arch Capital G | ACGLN | Nov 13, 2024 | 20.10 | -1.08 |
Arch Capital Group | ACGL | Nov 13, 2024 | 101.18 | +0.06 |
Arch Resources A | ARCH | Nov 13, 2024 | 164.84 | -1.07 |
Archer Aviation A | ACHR | Nov 13, 2024 | 4.28 | -8.15 |
Archer Daniels Midland | ADM | Nov 13, 2024 | 51.87 | +0.86 |
Archrock | AROC | Nov 13, 2024 | 23.66 | -2.31 |
Arcos Dorados | ARCO | Nov 13, 2024 | 8.60 | +2.38 |
Arcosa | ACA | Nov 13, 2024 | 103.18 | -0.39 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.